Pilot program to provide cheaper GLP-1 via Medicare raises concerns about shortages
As part of the program, Medicare will negotiate prices directly with pharmaceutical companies, potentially lowering out-of-pocket expenses for beneficiaries. However, this move has raised concerns among healthcare providers and patients alike regarding the potential for drug shortages, as manufacturers may struggle to meet increased demand at lower price points. For more information on the implications … Read more